Coronado Biosciences slips on Oppenheimer downgrade

Coronado Biosciences (CNDO) falls 4.8% premarket.

Behind the move looks to be Oppenheimer, where analysts have cut the shares to Perform from Outperform.

$2.50 price target removed.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs